Transaction #33052 · Form 4 · 0001213900-26-109157
Retension Pharmaceuticals, Inc. · Stock award · Stock Option (right to buy)
Retension Pharmaceuticals, Inc. · Transacted October 13, 2026 · Filed October 13, 2026
What does this filing report?
An SEC Form 4 filing for Retension Pharmaceuticals, Inc. records a stock award involving Stock Option (right to buy) on October 13, 2026. The reported quantity was 5,636. The filing date is October 13, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0002002988
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 5,636
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 5,636
- Ownership description
- Not reported
- SEC acceptance time
- Oct 13, 2026, 6:11 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Cheruvu Pavan ↗
Director
CIK 0001731741
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 5,636
- Conversion / exercise price
- 11.63
- Exercise date
- Not reported
- Expiration date
- October 13, 2036
Filing footnotes & remarks
- F1
- Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on the first anniversary of the date of grant, with the remaining stock options vesting in 12 quarterly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.